- Home
- XERS vs LXU Comparison
XERS vs LXU Comparison
Compare XERS & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | LXU |
|---|---|---|
| Founded | 2005 | 1968 |
| Country | United States | United States |
| Employees | N/A | 513 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | XERS | LXU |
|---|---|---|
| Price | $6.17 | $13.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $10.83 | ★ $14.63 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.00 | ★ 225.93 |
| EPS | 0.01 | ★ 0.27 |
| Revenue | $49,590,000.00 | ★ $615,208,000.00 |
| Revenue This Year | $34.37 | $13.69 |
| Revenue Next Year | $22.86 | N/A |
| P/E Ratio | $638.48 | ★ $47.89 |
| Revenue Growth | ★ 142.67 | 17.77 |
| 52 Week Low | $4.30 | $7.09 |
| 52 Week High | $10.08 | $17.22 |
Technical Indicators
Market Signals| Indicator | XERS | LXU |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 40.10 |
| Support Level | $5.79 | $8.03 |
| Resistance Level | $6.41 | $15.56 |
| Average True Range (ATR) | 0.32 | 0.71 |
| MACD | -0.02 | -0.20 |
| Stochastic Oscillator | 28.51 | 8.46 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.